Clinical studies recruiting near Marietta

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · WellStar Kennestone Hospital · Joseph Broderick, MD · NCT07227246 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Drug Studies America · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Wellstar Kennestone Hospital · NRG Oncology · NCT05624996 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 8400019 · Sanofi · NCT06958536 Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Phase N/A · Wellstar Health System · Vesalio · NCT06893588 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Northwest Georgia Oncology Centers, a Service of Wellstar Co · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0048 · Celgene · NCT05519085 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Northwest Georgia Oncology Centers, a Service of Wellstar Co · Merck Sharp & Dohme LLC · NCT07489495 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Marietta Memorial Hospital · NRG Oncology · NCT05174169 NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Phase N/A · Wellstar Research Institute · Medtronic Neurovascular Clinical Affairs · NCT06604884 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Marietta Memorial Hospital · National Cancer Institute (NCI) · NCT04269902 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Psych Atlanta, Pc · Xenon Pharmaceuticals Inc. · NCT06775379 Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Phase N/A · Wellstar Kennestone Regional Medical Center · Zeenat Qureshi Stroke Institute · NCT06402968 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Marietta Memorial Hospital · Alliance for Clinical Trials in Oncology · NCT04242095 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Marietta Memorial Hospital · National Cancer Institute (NCI) · NCT05256225 The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
Phase N/A · Wellstar Health System · HeartFlow, Inc. · NCT07479433 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Marietta Memorial Hospital · Eastern Cooperative Oncology Group · NCT05108298 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Northwest Georgia Oncology Centers PC ( Site 0061) · Merck Sharp & Dohme LLC · NCT03486873 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Marietta Memorial Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Gastrointestinal Specialists of Georgia PC · Ardelyx · NCT07382167 Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037 A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · Atlanta Research Center for Rheumatology · Eli Lilly and Company · NCT06864026 Medtronic Cardiac Surgery PMCF Registry
Phase N/A · WellStar Kennestone Hospital · Medtronic Cardiac Surgery · NCT04073420 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Marietta Memorial Hospital · Alliance for Clinical Trials in Oncology · NCT05677490

Look up another city

Look up another condition